{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:03:57Z","timestamp":1778493837602,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1186\/1471-2407-8-252","type":"journal-article","created":{"date-parts":[[2008,9,2]],"date-time":"2008-09-02T06:13:33Z","timestamp":1220336013000},"source":"Crossref","is-referenced-by-count":44,"title":["Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study"],"prefix":"10.1186","volume":"8","author":[{"given":"Sandro","family":"Pignata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Scarfone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Scollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Odicino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionyssios","family":"Katsaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Manzione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Lauria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiderio Gueli","family":"Alletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Ballardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra Vernaglia","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Mangili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Priolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Magni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,1]]},"reference":[{"key":"1190_CR1","volume-title":"Int J Gynecol Oncol","author":"ML Harrison","year":"2007","unstructured":"Harrison ML, Jameson G, Gore ME: Mucinous ovarian cancer. Int J Gynecol Oncol. 2007"},{"key":"1190_CR2","doi-asserted-by":"crossref","unstructured":"du Bois A, Quinn M, Thigpen T, Vermorken J, Avall-Lundqvist E, Bookman M, Bowtell D, Brady M, Casado A, Cervantes A, Eisenhauer E, Friedlaender M, Fujiwara K, Grenman S, Guastalla JP, Harper P, Hogberg T, Kaye S, Kitchener H, Kristensen G, Mannel R, Meier W, Miller B, Neijt JP, Oza A, Ozols R, Parmar M, Pecorelli S, Pfisterer J, Poveda A, Provencher D, Pujade-Lauraine E, Randall M, Rochon J, Rustin G, Sagae S, Stehman F, Stuart G, Trimble E, Vasey P, Vergote I, Verheijen R, Wagner U, Gynecologic Cancer Intergroup; AGO-OVAR; ANZGOG; EORTC; GEICO; GINECO; GOG; JGOG; MRC\/NCRI; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG; IGCS; Organizational team of the two prior International OCC: 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol. 2005, viii7-12. 10.1093\/annonc\/mdi961. Suppl 8","DOI":"10.1093\/annonc\/mdi961"},{"key":"1190_CR3","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1200\/JCO.2004.08.078","volume":"22","author":"V Hess","year":"2004","unstructured":"Hess V, A'Hern R, Nasiri N, King DM, Blake PR, Barton DP, Shepherd JH, Ind T, Bridges J, Harrington K, Kaye SB, Gore ME: Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment. J Clin Oncol. 2004, 22: 1040-1044. 10.1200\/JCO.2004.08.078.","journal-title":"J Clin Oncol"},{"key":"1190_CR4","first-page":"3501","volume":"25","author":"C Pisano","year":"2005","unstructured":"Pisano C, Greggi S, Tambaro R, Losito S, Iodice F, Di Maio M, Ferrari E, Falanga M, Formato R, Iaffaioli VR, Pignata S: Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study. Anticancer Res. 2005, 25: 3501-3505.","journal-title":"Anticancer Res"},{"issue":"A1797","key":"1190_CR5","first-page":"447","volume":"22","author":"T Enomoto","year":"2003","unstructured":"Enomoto T, Kuragakin C, Yamasaki M: Is clear cell carcinoma and mucinous carcinoma of ovary sensitive to combination chemotherapy with paclitaxel and carboplatin?. Proc Am Soc Clin Oncol. 2003, 22 (A1797): 447-","journal-title":"Proc Am Soc Clin Oncol"},{"key":"1190_CR6","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ygyno.2005.07.022","volume":"99","author":"D Pectasides","year":"2005","unstructured":"Pectasides D, Fonutrilas G, Aravantinos G, Kalofanos HP, Efstathion E, Salamalekis E: stage mucinous epithelial ovarian cancer; the Hellenic Cooperative Oncology Group experience. Gynecol Oncol. 2005, 99: 788-790. 10.1016\/j.ygyno.2005.07.022.","journal-title":"Gynecol Oncol"},{"key":"1190_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000108592","volume":"71","author":"S Pignata","year":"2007","unstructured":"Pignata S, Ferrandina G, Scarfone G, Scollo P, Odicino F, Selvaggi L, Katsaros D, Frigerio L, Mereu L, Grezzi F, Manzione L, Lauria R, Breda E, Martorio G, Ballardini M, Vernaglia Lombardi A, Sorio R, Tumolo S, Costa B, Magni G, Perrone F, Favalli G: Extending the platinum-free interval with a non platinum therapy in platinum sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study. Oncology. 2007, 71: 320-326. 10.1159\/000108592.","journal-title":"Oncology"},{"key":"1190_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000, 92: 205-216. 10.1093\/jnci\/92.3.205.","journal-title":"J Natl Cancer Inst"},{"key":"1190_CR9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.1996.14.5.1545","volume":"14","author":"GJ Rustin","year":"1996","unstructured":"Rustin GJ, Nelstrop AE, McClean P, Brady MF, McGuire WP, Hoskins WJ, Mitchell H, Lambert HE: Defining response of ovarian carcinoma to initial chemotherapy according to serum Ca 125. J Clin Oncol. 1996, 14: 1545-1550.","journal-title":"J Clin Oncol"},{"key":"1190_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Non parametric estimation from incomplete observation. J Am Stat Assoc. 1958, 53: 457-481. 10.2307\/2281868.","journal-title":"J Am Stat Assoc"},{"key":"1190_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ygyno.2006.02.015","volume":"103","author":"F Kikkawa","year":"2006","unstructured":"Kikkawa F, Nawa A, Kajiyama H, Shibata K, Ino K, Nomura S: Clinical Charcateristics and prognosis of mucinous tumours of the ovary. Gynecol Oncol. 2006, 103: 171-175. 10.1016\/j.ygyno.2006.02.015.","journal-title":"Gynecol Oncol"},{"key":"1190_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1006\/gyno.2001.6536","volume":"84","author":"V McGuire","year":"2002","unstructured":"McGuire V, Jesser CA, Whittemore AS: Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol. 2002, 84: 399-403. 10.1006\/gyno.2001.6536.","journal-title":"Gynecol Oncol"},{"key":"1190_CR13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1991.9.7.1138","volume":"9","author":"GA Omura","year":"1991","unstructured":"Omura GA, Brady MF, Homesley HD, Yordan E, Major FJ, Buchsbaum HJ, Park RC: Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Ginecologic Oncology Group experience. J Clin Oncol. 1991, 9: 1138-1150.","journal-title":"J Clin Oncol"},{"key":"1190_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ygyno.2003.09.030","volume":"92","author":"NG Cloven","year":"2004","unstructured":"Cloven NG, Kyshtoobayeva A, Burger RA, Yu IR, Fruehauf JP: In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovariancancer. Gynecol Oncol. 2004, 92: 160-6. 10.1016\/j.ygyno.2003.09.030.","journal-title":"Gynecol Oncol"},{"key":"1190_CR15","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","volume":"361","author":"MK Parmar","year":"2003","unstructured":"Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, Floriani I, Jayson G, Lamont A, Trope C, ICON and AGO Collaborators: Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial. Lancet. 2003, 361: 2099-2106. 10.1016\/S0140-6736(03)13718-X.","journal-title":"Lancet"},{"key":"1190_CR16","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","volume":"24","author":"J Pfisterer","year":"2006","unstructured":"Pfisterer J, Plante M, Vergote I, du Bois A, Hirte H, Lacave AJ, Wagner U, Stahle A, Stuart G, Kimmig R, Olbricht S, Le T, Emerich J, Kuhn W, Bentley J, Jackisch C, Luck HJ, Rochon J, Zimmermann AH, Eisenhauer E, AGO-OVAR; NCIC CTG; EORTC GCG: Gemcitabine\/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA). J Clin Oncol. 2006, 24: 4699-707. 10.1200\/JCO.2006.06.0913.","journal-title":"J Clin Oncol"},{"key":"1190_CR17","first-page":"777","volume":"139","author":"T Enomoto","year":"1991","unstructured":"Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rice JM: K-ras activation occur frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the ovary. J Pathol. 1991, 139: 777-85.","journal-title":"J Pathol"},{"key":"1190_CR18","first-page":"33","volume":"54","author":"Y Ichikawa","year":"1994","unstructured":"Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K, Miwa M: Mutation of K-ras protooncogene is associated with histological subtype in human mucinous ovarian tumors. Cancer Res. 1994, 54: 33-5.","journal-title":"Cancer Res"},{"key":"1190_CR19","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T","volume":"79","author":"M Cuatrecasas","year":"1997","unstructured":"Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J: K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer. 1997, 79: 1581-6. 10.1002\/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T.","journal-title":"Cancer"},{"issue":"10","key":"1190_CR20","first-page":"2984","volume":"7","author":"A Reles","year":"2001","unstructured":"Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Sch\u00f6nborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF: Correlation of p53 mutation to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res. 2001, 7 (10): 2984-2997.","journal-title":"Clin Cancer Res"},{"key":"1190_CR21","first-page":"31","volume":"8","author":"Y Matsumoto","year":"2001","unstructured":"Matsumoto Y, Ishiko O, Deguchi M, Nakagawa E, Ogita S: Cyclooxigenase-2 expression in normal ovaries and epithelial ovarian neoplasm. Int J Mol Med. 2001, 8: 31-6.","journal-title":"Int J Mol Med"},{"key":"1190_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0002-9440(10)64912-7","volume":"160","author":"C Denkert","year":"2002","unstructured":"Denkert C, K\u00f6bel M, Pest S, Koch I, Berger S, Schwabe M, Siegert A, Reles A, Klosterhalfen B, Hauptmann S: Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol. 2002, 160: 893-903.","journal-title":"Am J Pathol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-8-252\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-8-252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T19:23:04Z","timestamp":1557775384000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-8-252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-8-252","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,1]]},"article-number":"252"}}